125.32
2.71 (2.21%)
| Penutupan Terdahulu | 122.61 |
| Buka | 124.99 |
| Jumlah Dagangan | 389,984 |
| Purata Dagangan (3B) | 616,121 |
| Modal Pasaran | 4,049,936,384 |
| Harga / Jualan (P/S) | 5.37 |
| Harga / Buku (P/B) | 26.53 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 30 Apr 2026 |
| Margin Keuntungan | -15.90% |
| Margin Operasi (TTM) | -19.49% |
| EPS Cair (TTM) | -3.12 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 20.30% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 848.67% |
| Nisbah Semasa (MRQ) | 5.71 |
| Aliran Tunai Operasi (OCF TTM) | 47.53 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | 26.95 M |
| Pulangan Atas Aset (ROA TTM) | -4.37% |
| Pulangan Atas Ekuiti (ROE TTM) | -111.13% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Medical Devices (US) | Bercampur | Menurun |
| Medical Devices (Global) | Bercampur | Menurun | |
| Stok | iRhythm Holdings, Inc. | Menurun | Menaik |
AISkor Stockmoo
| Konsensus Penganalisis | 3.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | 4.5 |
| Purata Bergerak Teknikal | 1.5 |
| Osilator Teknikal | 2.0 |
| Purata | 2.75 |
|
iRhythm Technologies Inc is a digital healthcare company that creates trusted solutions that detect, predict, and prevent disease. Its principal business is the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services that it believes allow clinicians to diagnose certain arrhythmias quicker and with greater efficiency than other services that rely on traditional technology. Each Zio System combines an FDA-cleared and CE-marked, wire-free, patch-based, 14-day wearable biosensor that continuously records electrocardiogram (ECG) data with a proprietary, FDA-cleared, CE-marked cloud-based data analytic software to help physicians monitor patients and diagnose arrhythmias. |
|
| Sektor | Healthcare |
| Industri | Medical Devices |
| Gaya Pelaburan | Small Growth |
| % Dimiliki oleh Orang Dalam | 1.08% |
| % Dimiliki oleh Institusi | 115.08% |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 215.00 (JP Morgan, 71.56%) | Beli |
| Median | 200.00 (59.59%) | |
| Rendah | 198.00 (Canaccord Genuity, 58.00%) | Beli |
| Purata | 204.50 (63.18%) | |
| Jumlah | 6 Beli | |
| Harga Purata @ Panggilan | 144.12 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| Citigroup | 11 Mar 2026 | 214.00 (70.76%) | Beli | 119.64 |
| Truist Securities | 23 Feb 2026 | 200.00 (59.59%) | Beli | 141.22 |
| Baird | 20 Feb 2026 | 200.00 (59.59%) | Beli | 150.96 |
| Canaccord Genuity | 20 Feb 2026 | 198.00 (58.00%) | Beli | 150.96 |
| JP Morgan | 20 Feb 2026 | 215.00 (71.56%) | Beli | 150.96 |
| Wells Fargo | 20 Feb 2026 | 200.00 (59.59%) | Beli | 150.96 |
Tiada data dalam julat masa ini.
| Tarikh | Jenis | Butiran |
|---|---|---|
| 05 Feb 2026 | Pengumuman | iRhythm Holdings to Report Fourth Quarter and Full Year 2025 Financial Results on February 19, 2026 |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |